Nilotinib vs dasatinib in achieving MR4.5 for de novo chronic myeloid leukemia: the randomized JALSG CML212 study

Matsumura, Itaru, Ohtake, Shigeki, Atsuta, Yoshiko · Blood Advances · 2024